Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo in Autism Spectrum Disorder

Summary

This is a randomized, double-blind, 2-arm, placebo-controlled crossover study in pediatric patients with autism spectrum disorder with all patients receiving 16-weeks of TSO treatment and 16 weeks of placebo.

Timeline

Start

2014-05

Primary completion

2015-04

Completion

2015-04

Outcome

Outcome not reported

Stopped: “A preliminary analysis of data from this trial failed to demonstrate any signal of activity.”

Drugs

Indications